Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03544281 |
Title | To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM) |
Acronym | DREAMM 6 |
Recruitment | Completed |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | GlaxoSmithKline |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | GBR | ESP | CAN | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
GSK Investigational Site | Birmingham | Alabama | 35294 | United States | Details | |
GSK Investigational Site | Goodyear | Arizona | 85338 | United States | Details | |
GSK Investigational Site | Atlanta | Georgia | 30322-4200 | United States | Details | |
GSK Investigational Site | Indianapolis | Indiana | 46202 | United States | Details | |
GSK Investigational Site | Lansing | Michigan | 48910 | United States | Details | |
GSK Investigational Site | Saint Louis | Missouri | 63110 | United States | Details | |
GSK Investigational Site | Grand Island | Nebraska | 68803 | United States | Details | |
GSK Investigational Site | Hackensack | New Jersey | 07601 | United States | Details | |
GSK Investigational Site | Bronx | New York | 10467 | United States | Details | |
GSK Investigational Site | New York | New York | 10022 | United States | Details | |
GSK Investigational Site | Greer | South Carolina | 29650 | United States | Details | |
GSK Investigational Site | Dallas | Texas | 75251 | United States | Details | |
GSK Investigational Site | Wollongong | New South Wales | 2500 | Australia | Details | |
GSK Investigational Site | Woodville | South Australia | 5011 | Australia | Details | |
GSK Investigational Site | Fitzroy | Victoria | 3065 | Australia | Details | |
GSK Investigational Site | Melbourne | Victoria | 3000 | Australia | Details | |
GSK Investigational Site | Melbourne | Victoria | 3004 | Australia | Details | |
GSK Investigational Site | Murdoch | Western Australia | 6150 | Australia | Details | |
GSK Investigational Site | Nedlands | Western Australia | 6009 | Australia | Details | |
GSK Investigational Site | Montreal | Quebec | H1T 2M4 | Canada | Details | |
GSK Investigational Site | Barcelona | 8035 | Spain | Details | ||
GSK Investigational Site | Madrid | 28040 | Spain | Details | ||
GSK Investigational Site | Madrid | 28050 | Spain | Details | ||
GSK Investigational Site | Salamanca | 37007 | Spain | Details | ||
GSK Investigational Site | Truro | Cornwall | TR1 3LJ | United Kingdom | Details | |
GSK Investigational Site | London | W1T 7HA | United Kingdom | Details |